«

NSF funded Innovation in Minimally Invasive Orthopedic Fracture Fixation

Read: 1828



Medicarbone Inc.

Project ## Design and Development of Minimally-Invasive Orthopedic Fracture Fixation Using Intramedullary Sleeve and Injectable, Light-Triggered Bone Cement

Leadership Team:

Funding Timeline:

Funding Organization:

National Science Foundation NSF

Program Director: Henry Ahn

Abstract Overview:

This Small Business Innovation Research SBIR Phase I project addresses the pressing need for advancements in orthopedic procedures. The goal is to innovate and provide less invasive solutions that stabilize and repr fractured bones using an intramedullary nl technique enhanced with a light-triggered bone cement system.

The objectives m to:

  1. Develop multi-layered intramedullary IM sleeve prototypes.

  2. Synthesize and optimize the in situ, photopolymerizable polymeric resin system for IM sleeves.

  3. Create removal methods for cured polymers using minimally invasive tools.

  4. Evaluate biocompatibility and showcase device efficacy through in vitro and cadaveric testing.

This research will contribute to advancements in bone fracture healing techniques and potentially streamline surgical procedures for better patient outcomes, reducing complications and costs associated with traditional methods.

Errata:

For any errors or discrepancies in the award information, please contact [email protected].


Company Profile:

The information provided is subject to the following:

Award History:

Explore related awards from NSF startups and small businesses by clicking here.


of Document
This article is reproduced from: https://seedfund.nsf.gov/awardees/phase-1/details/?company=medicarbone-inc

Please indicate when reprinting from: https://www.p092.com/Drug_capsules/Medicarbone_Intramedullary_Fracture_Solution.html

Minimally Invasive Bone Fixation Technique Light Triggered Bone Cement System Intramedullary Sleeve Prototypes Development Orthopedic Fracture Repair Innovation NSF SBIR Phase I Project Funding Advanced Biocompatible Device Efficacy